OSR Holdings Inc (OSRH) - Total Liabilities
Based on the latest financial reports, OSR Holdings Inc (OSRH) has total liabilities worth $44.20 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
OSR Holdings Inc - Total Liabilities Trend (2020–2025)
This chart illustrates how OSR Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. See OSRH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
OSR Holdings Inc Competitors by Total Liabilities
The table below lists competitors of OSR Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gold By Gold
PA:ALGLD
|
France | €3.39 Million |
|
Tecom Co Ltd
TW:2321
|
Taiwan | NT$781.71 Million |
|
WIN Metals Ltd
AU:WIN
|
Australia | AU$3.69 Million |
|
COCRYSTAL PHARMA NEW O.N.
F:8CC
|
Germany | €3.38 Million |
|
Sable Resources Ltd
V:SAE
|
Canada | CA$2.82 Million |
|
Carnegie Clean Energy Limited
F:CNM1
|
Germany | €8.29 Million |
|
Horseshoe Metals Ltd
AU:HOR
|
Australia | AU$11.47 Million |
|
Privasia Technology Bhd
KLSE:0123
|
Malaysia | RM210.04 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down OSR Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see OSRH company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.57 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how OSR Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for OSR Holdings Inc (2020–2025)
The table below shows the annual total liabilities of OSR Holdings Inc from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $44.20 Million | +402.92% |
| 2024-12-31 | $8.79 Million | +113.93% |
| 2023-12-31 | $4.11 Million | +23763.66% |
| 2022-12-31 | $17.22K | -97.57% |
| 2021-12-31 | $707.21K | +119.93% |
| 2020-12-31 | $321.56K | -- |
About OSR Holdings Inc
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Germany, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the… Read more